Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Phase 2 Single-Arm, Open-Label Study of Nivolumab in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) Phase 2 Single-Arm, Open-Label Study of Nivolumabin Patients With Relapsed or Refractory Peripheral ...